Skip to main content

Table 4 Baseline and 16-week differences in serum sex hormones and treatment effects between study groups

From: Effect of weight loss, with or without exercise, on body composition and sex hormones in postmenopausal women: the SHAPE-2 trial

 

Baseline geometric mean

Geometric mean at 16 wk

Change at 16 wk, %

TERa (95 % CI), intervention vs control

P value*

TERa (95 % CI), mainly exercise vs diet

P value**

Oestradiol (pg/ml)

       
 

Control

3.89

4.01

3.11

    
 

Diet

4.20

3.62

−13.8

0.86 (0.75–0.98)

0.025

  
 

Mainly exercise

3.69

3.22

−12.7

0.83 (0.73–0.95)

0.007

0.97 (0.87–1.08)

0.562

Oestrone (pg/ml)

       
 

Control

20.1

20.4

1.51

    
 

Diet

20.4

20.1

−1.26

0.98 (0.88–1.08)

0.650

  
 

Mainly exercise

19.9

18.5

−6.67

0.92 (0.82–1.02)

0.109

0.94 (0.86–1.02)

0.154

Free oestradiol (pg/ml)

       
 

Control

0.09

0.10

3.23

    
 

Diet

0.10

0.08

−17.7

0.80 (0.70–0.92)

0.002

  
 

Mainly exercise

0.09

0.07

−19.1

0.77 (0.67–0.88)

<0.001

0.96 (0.85–1.07)

0.425

Testosterone (pg/ml)

       
 

Control

194

186

−4.07

    
 

Diet

197

189

−3.76

1.01 (0.92–1.10)

0.886

  
 

Mainly exercise

186

172

−7.63

0.96 (0.87–1.05)

0.332

0.95 (0.88–1.02)

0.166

Androstenedione (pg/ml)

       
 

Control

575

560

−2.60

    
 

Diet

562

537

−4.50

0.97 (0.85–1.12)

0.684

  
 

Mainly exercise

573

488

−14.7

0.87 (0.76–1.00)

0.059

0.90 (0.80–1.01)

0.064

Free testosterone (pg/ml)

       
 

Control

2.71

2.61

−3.90

    
 

Diet

2.53

2.25

−11.2

0.91 (0.83–1.01)

0.069

  
 

Mainly exercise

2.44

2.01

−17.7

0.84 (0.76–0.93)

0.001

0.92 (0.85–0.99)

0.043

SHBG (nmol/L)

       
 

Control

44.2

44.0

−0.30

    
 

Diet

50.7

57.1

12.6

1.14 (1.07–1.23)

<0.001

  
 

Mainly exercise

49.3

58.6

19.0

1.21 (1.12–1.30)

<0.001

1.05 (1.00–1.12)

0.070

  1. Baseline and follow-up measurements of complete cases (i.e., women with both baseline and follow-up measurements) are presented. Complete case data of oestradiol were available for 223 women; oestrone for 221 women; free oestradiol for 222 women; testosterone and androstenedione for 229 women; free testosterone for 228 women; and SHBG for 230 women
  2. Abbreviations: CI confidence interval, SHBG sex hormone-binding hormone, TER treatment effect ratio
  3. *P < 0.025 was considered significant for the comparison of both intervention groups vs control
  4. **P < 0.05 was considered significant for the comparison mainly exercise vs diet
  5. aTER represents the overall intervention effect on hormone change (adjusted for baseline), estimated by linear regression analysis. Because the linear regression models were based on log-transformed hormone data, the presented treatment effect is the antilogarithm of the original estimate. Therefore, the TER is a ratio that indicates how many times the level in one group is higher (TER >1) or lower (TER <1) than a reference group. For example, TER intervention vs control of 0.9 indicates that the hormone level in the intervention group is, on average, 10 % lower than in the control group